LATISSE® grows lashes longer, fuller and darker.
LATISSE® is the only FDA-approved prescription treatment to treat inadequate or thin lashes, growing them longer, fuller and darker.
This growth treatment for hypotrichosis (inadequate or not enough eyelashes) is clinically proven to grow lashes, the only lash growth product of its kind available by prescription.
LATISSE® solution is a once-nightly topical treatment applied to the base of the upper eyelashes, as instructed by your healthcare provider. For some increased length and volume is visible in as little as four weeks, with full growth apparent in 16 weeks.
How LATISSE® works.
LATISSE® makes lash growth possible because of its The active ingredient bimatoprost is believed to affect the growth (anagen) phase of the eyelash hair cycle in two ways: 1.) increasing the length of this phase and 2.) increasing the number of hairs in this growth phase.
Created by Allergan in 2001, the LATISSE® solution was initially developed as a medicated eye drop to treat elevated intraocular pressure. As a side-effect, many patients also began to grow fuller, darker lashes. Allergan scientists began to study the medication’s active ingredient, bimatoprost, specifically for growing lashes. After a clinical trial, LATISSE® was approved by the FDA in December 2008 to grow lashes.
DermaTouch RN provides LATISSE lash growing products, consulting with patients on its proper use and associated contraindications.